La Jolla Pharmaceutical Company Stock OTC Bulletin Board
Equities
US5034596040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | La Jolla Pharmaceutical Announces Management Changes | CI |
2022 | La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index | CI |
Managers | Title | Age | Since |
---|---|---|---|
Michael Hearne
DFI | Director of Finance/CFO | 61 | 20-05-31 |
Tony Hodges
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-11 |
Luke Seikkula
COO | Chief Operating Officer | 60 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marianne Zhen
BRD | Director/Board Member | 55 | 22-08-21 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 22-08-21 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |